Cargando…

Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec

Background: The introduction of novel hormonal agents (NHAs) such as abiraterone acetate (ABI) and enzalutamide (ENZ) for metastatic castration-resistant prostate cancer (mCRPC) was an important milestone given their survival benefits, tolerability, and ease of administration relative to taxane chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jason, Aprikian, Armen G., Saleh, Ramy R., Dragomir, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688923/
https://www.ncbi.nlm.nih.gov/pubmed/36421333
http://dx.doi.org/10.3390/curroncol29110680